0.2625
Precedente Chiudi:
$0.2669
Aprire:
$0.27
Volume 24 ore:
577.92K
Relative Volume:
1.60
Capitalizzazione di mercato:
$9.83M
Reddito:
$7.11M
Utile/perdita netta:
$-41.28M
Rapporto P/E:
-0.1902
EPS:
-1.38
Flusso di cassa netto:
$-26.84M
1 W Prestazione:
+0.31%
1M Prestazione:
+5.42%
6M Prestazione:
-64.04%
1 anno Prestazione:
-79.33%
Co Diagnostics Inc Stock (CODX) Company Profile
Nome
Co Diagnostics Inc
Settore
Industria
Telefono
(801) 278-9769
Indirizzo
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Confronta CODX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CODX
Co Diagnostics Inc
|
0.2625 | 9.83M | 7.11M | -41.28M | -26.84M | -1.38 |
![]()
ABT
Abbott Laboratories
|
134.38 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
106.53 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
393.55 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
86.02 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
78.21 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2022-08-12 | Downgrade | Sidoti | Buy → Neutral |
2021-12-29 | Iniziato | Sidoti | Buy |
2021-03-29 | Downgrade | Maxim Group | Buy → Hold |
2020-05-20 | Aggiornamento | Maxim Group | Hold → Buy |
2020-05-18 | Reiterato | H.C. Wainwright | Buy |
2020-03-09 | Reiterato | H.C. Wainwright | Buy |
2020-03-03 | Downgrade | Maxim Group | Buy → Hold |
Mostra tutto
Co Diagnostics Inc Borsa (CODX) Ultime notizie
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys, Deadline Approaching in Securities Class Action - ACCESS Newswire
CODX INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm - ACCESS Newswire
Co-Diagnostics, Inc. (NASDAQ:CODX) Short Interest Up 19.5% in May - Defense World
Co-Diagnostics completes first FDA 510(k) application for Co-Dx PCR Pro - TipRanks
Co-Diagnostics Holds Annual Shareholders Meeting - TipRanks
Co-Diagnostics stock hits 52-week low at $0.27 amid market challenges - Investing.com Australia
Major health care company files for bankruptcy to sell assets - TheStreet
HC Wainwright Predicts Co-Diagnostics Q1 Earnings - Defense World
Q2 EPS Estimates for Co-Diagnostics Raised by HC Wainwright - Defense World
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference | CODX Stock News - GuruFocus
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference - The Manila Times
Co-Diagnostics, Inc. to Participate in D. Boral Capital Inaugural Global Conference on May 14, 2025 - Nasdaq
Co-Diagnostics Unveils Next-Gen PCR Testing Platform to Elite Institutional Investors - Stock Titan
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Co-Diagnostics Q1 2025 shows improved EPS and revenue decline - Investing.com Nigeria
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Stra - GuruFocus
Co-Diagnostics Q1 2025 Earnings Call Transcript - MarketBeat
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid Revenue ... - Yahoo Finance
Co-Diagnostics Reports Q1 2025 Financial Results - TipRanks
Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue Estimates - MSN
Co-Diagnostics Inc Reports Q1 2025 Earnings: EPS Loss of $0.24 Beats Estimates, Revenue Falls Short at $0.1 Million - GuruFocus
Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results - The Manila Times
Examining the Future: Co-Diagnostics's Earnings Outlook - Nasdaq
Resmed acquires virtual diagnostics company VirtuOx - MassDevice
Co-Diagnostics (NASDAQ:CODX) Stock Rating Upgraded by D Boral Capital - Defense World
D. Boral Capital Initiates Coverage of Co-Diagnostics (LSE:0A50) with Buy Recommendation - Nasdaq
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Relea - GuruFocus
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast - GlobeNewswire
Co-Diagnostics Q1 2025 Earnings Coming May 8: Key Executive Team to Present Latest Financial Performance - Stock Titan
Stock Market Recap: Co-Diagnostics Inc (CODX) Concludes at 0.32, a -18.26 Surge/Decline - DWinneX
Co-Diagnostics (NASDAQ:CODX) Now Covered by Analysts at D. Boral Capital - Defense World
Co-Diagnostics expands sales agreement, adds Clear Street as agent By Investing.com - Investing.com Canada
Co-Diagnostics expands sales agreement, adds Clear Street as agent - Investing.com Australia
This Kohl's Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Benzinga
D. Boral Capital Initiates Coverage of Co-Diagnostics (CODX) with Buy Recommendation - Nasdaq
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. - Seeking Alpha
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results - Seeking Alpha
Co-Diagnostics Inc (NASDAQ: CODX): Is This The Time To Buy? - Marketing Sentinel
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges - Investing.com Canada
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges By Investing.com - Investing.com South Africa
Many med-tech company supply chains protected from tariffs - BioWorld MedTech
All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy - Yahoo Finance
Co-Diagnostics targets 2025 clinical evaluations for TB and HPV tests in India and South Africa - MSN
Co Diagnostics Inc Azioni (CODX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):